Evidence map›Paper›PMID 38626431›Full record

ArticleInternational journal of surgery (London, England)2024

Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.

Xue-Lei Li, Zhi-Peng Liu, Xing-Xing Su, Yi Gong, Yi-Shi Yang, Xiao-Lin Zhao, Zi-Mu Li, Jun-Jie Ding, Yi Zhu, Da-Long Yin and 16 more

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in International journal of surgery (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 5 countries.

Xue-Lei LiDepartment of Hepatobiliary Surgery, Southwest Hospital.
Zhi-Peng LiuDepartment of Hepatobiliary Surgery, Southwest Hospital.
Xing-Xing SuDepartment of Hepatobiliary Surgery, Southwest Hospital.
Yi GongDepartment of Hepatobiliary Surgery, Southwest Hospital.
Yi-Shi YangDepartment of Hepatobiliary Surgery, Southwest Hospital.
Xiao-Lin ZhaoDepartment of Hepatobiliary Surgery, Southwest Hospital.
Zi-Mu LiDepartment of Hepatobiliary Surgery, Southwest Hospital.
Jun-Jie DingDepartment of Hepatobiliary Surgery, Southwest Hospital.
Yi ZhuDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Zhejiang University.
Da-Long YinDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of University of Science and Technology of China, Hefei.
Chao YuDepartment of Hepatobiliary Surgery, Affiliated Hospital of Guizhou Medical University, Guizhou.
Jin-Xue ZhouDepartment of Hepatobiliary Pancreatic Surgery, Henan Provincial Tumor Hospital, Zhengzhou.
Dong ZhangDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University.
Rui DingDepartment of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University (Air Force Medical University), Xi'an.
Wei ChenDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Zhongshan.
Yao ChengDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing.
Ping YueDepartment of Hepatobiliary Surgery, Lanzhou University First Hospital, Lanzhou.
Zi-Ran WangDepartment of General Surgery, 903rd Hospital of People's Liberation Army, Hangzhou.
Yan-Qi ZhangDepartment of Health Statistics, College of Military Preventive Medicine, Third Military Medical University (Army Medical University).
Yan JiangDepartment of Hepatobiliary Surgery, Southwest Hospital.
Xian-Yu YinDepartment of Hepatobiliary Surgery, Southwest Hospital.
Jie BaiDepartment of Hepatobiliary Surgery, Southwest Hospital.
Hai-Su DaiDepartment of Hepatobiliary Surgery, Southwest Hospital.
Wan Yee LauFaculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, People's Republic of China.
Zhi-Yu ChenDepartment of Hepatobiliary Surgery, Southwest Hospital.
Biliary Surgery Branch of Elite Group of Chinese Digestive Surgery (EGCDS)
Southwest General Health Center · USRatio · SEArmy Medical University · CNCommunity Cancer Center · USSun Yat-sen University · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic value of carbohydrate antigen 19-9 (CA19-9) is known to be affected by elevated bilirubin levels in patients with gallbladder carcinoma (GBC). The clinical significance of changes in the ratio of CA19-9 levels to total bilirubin (TB) levels in patients with GBC after curative-intent resection remains unknown. The aim of this study was to determine the prognostic value of changes in preoperative and postoperative CA19-9/TB ratio in these patients.

methodsProspectively collected data on consecutive patients who underwent curative-intent resection for GBC between January 2015 and December 2020 stored in a multicenter database from 10 hospitals were analyzed in this retrospective cohort study. Based on the adjusted CA19-9 defined as the ratio of CA19-9 to TB, and using 2×10 3  U/µmol as the upper normal value, patients were divided into a normal group (with normal preoperative and postoperative adjusted CA19-9), a normalization group (with abnormal preoperative but normal postoperative adjusted CA19-9), and a non-normalization group (with abnormal postoperative adjusted CA19-9). The primary outcomes were overall survival (OS) and recurrence-free survival (RFS). The log-rank test was used to compare OS and RFS among the groups. The Cox regression model was used to determine factors independently associated with OS and RFS.

resultsThe normal group ( n =179 patients) and the normalization group ( n =73 patients) had better OS and RFS than the non-normalization group ( n =65 patients) (the 3-year OS rates 72.0%, 58.4% and 24.2%, respectively; the RFS rates 54.5%, 25.5% and 11.8%, respectively; both P <0.001). There were no significant differences between the normal and the normalization groups in OS and RFS (OS, P =0.255; RFS, P =0.130). Cox regression analysis confirmed that the non-normalization group was independently associated with worse OS and RFS. Subgroup analysis revealed that the non-normalization group of patients who received adjuvant therapy had significantly improved OS and RFS as compared to those who did not receive adjuvant therapy (OS, P =0.025; RFS, P =0.003).

conclusionsPatients with GBC who underwent curative-intent surgical resection with postoperative abnormal levels of adjusted CA19-9 (the CA19-9/TB ratio) were associated with poorer long-term survival outcomes. Adjuvant therapy after surgery improved the long-term outcomes of these patients.

Indexed as

BilirubinCA-19-9 AntigenGallbladder NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesBilirubinCA-19-9 Antigen

Identifiers

PMID38626431
PMCPMC11175767
OpenAlexW4394840483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.